Protocols
1 protocol(s) meet the specified criteria
Drug: MSB0011359C
Protocol No.TitleStatus
EMR200647-001A Phase I, open-label, multiple-ascending dose trial to investigate the safety, tolerability, pharmacokinetics, biological and clinical activity of MSB0011359C in subjects with metastatic or locally advanced solid tumors and expansion to selected indicationOpen